Literature DB >> 30197035

Varian Halcyon dosimetric comparison for multiarc VMAT prostate and head-and-neck cancers.

Catalina Riley1, Christopher Cox2, Sasha Graham2, Holly Havran2, Bethany Kramer2, Tucker Netherton2, Christine Peterson2, Tyler Williamson2, Laurence Court2.   

Abstract

The Varian Halcyon linear accelerator is designed for faster treatment time and fewer treatment errors than conventional linear accelerators. Its increased gantry speed (4 rpm), dose rate (800 MU/min), and leaf speed (5 cm/s) reduce treatment time. The 2 multileaf collimator banks of 1 cm leaf width could cause planning difficulties, but utilizing many arcs could address this challenge. While 3 or more arcs are often avoided due to the increased treatment time, the Halcyon can deliver 5 arcs in under 3 minutes. For prostate and head-and-neck, we hypothesized plan quality would increase with increasing arcs without compromising treatment time. Fifteen prostate and fifteen head-and-neck previously treated patients were replanned to 78 and 66 Gy, respectively. A total of 150 volumetric modulated arc therapy (VMAT) plans, ranging from 1 to 5 arcs, were created to compare organ-at-risk (OAR) sparing, target coverage, homogeneity, and hotspot volume. Plans were normalized to the prescribed dose of 98% and 95% of the primary target volume for prostate and head-and-neck, respectively. All prostate 4-arc and 5-arc plans met MD Anderson Cancer Center (MDACC) constraints, while 86.7%, 20%, and 6.7% of the 1-arc, 2-arc, and 3-arc plans did not meet constraints, respectively. As the number of arcs increased, all OAR maximum doses decreased. All head-and-neck 5-arc plans met MDACC constraints, while 73.3%, 26.7%, 13.3%, and 6.7% of the 1-arc, 2-arc, 3-arc, and 4-arc plans did not meet constraints, respectively. The contralateral parotid mean dose and the spinal cord maximum dose decreased with increasing arcs. Homogeneity and conformity indices decreased when increasing from 1 to 5 arcs for both prostate and head-and-neck. Overall, homogeneity and conformity indices and OAR doses improved when using three or more arcs. Therefore, using at least 3 arcs for VMAT plans on the Halcyon will increase plan quality without compromising treatment time.
Copyright © 2018 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2018        PMID: 30197035     DOI: 10.1016/j.meddos.2018.06.004

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  4 in total

1.  Dosimetric Characterization of the Dual Layer MLC System for an O-Ring Linear Accelerator.

Authors:  Michele M Kim; Douglas Bollinger; Chris Kennedy; Wei Zou; Ryan Scheuermann; Boon-Keng Kevin Teo; James M Metz; Lei Dong; Taoran Li
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec

2.  Investigation of Halcyon multi-leaf collimator model in Eclipse treatment planning system: A focus on the VMAT dose calculation with the Acuros XB algorithm.

Authors:  Ryohei Miyasaka; SangYong Cho; Takuya Hiraoka; Kohei Chiba; Toru Kawachi; Tetsurou Katayose; Yuhi Suda; Ryusuke Hara
Journal:  J Appl Clin Med Phys       Date:  2022-01-09       Impact factor: 2.102

3.  Examination of conversion method of dose distribution of lung cancer IMRT using fluence reversible calculation function in O-ring type linac and C-type linac.

Authors:  Toshiya Rachi; Raturi Vijay Parshuram; Yuki Tanaka; Haruki Togo
Journal:  Phys Eng Sci Med       Date:  2022-04-19

4.  Early clinical experience with varian halcyon V2 linear accelerator: Dual-isocenter IMRT planning and delivery with portal dosimetry for gynecological cancer treatments.

Authors:  Hayeon Kim; M Saiful Huq; Ron Lalonde; Christopher J Houser; Sushil Beriwal; Dwight E Heron
Journal:  J Appl Clin Med Phys       Date:  2019-10-29       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.